GLSI

Greenwich LifeSciences, Inc.

Healthcare · Biotechnology

$116.52 sample

-0.89 (-0.76%) 1D

Market cap

$552.3B

Price as of

2026-10-04

Latest filing

8-K · 2026-09-15

Alerts

8

Price$116.52 +13.12% 3M daily closessample

118.72103.01

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 29INSInsider buy: 10% owner
Sep 23INSInsider sell: Chief Executive Officer
Sep 18INSInsider sell: 10% owner
Sep 15SECForm 144 filed
Sep 10INSInsider sell: EVP, Operations
Sep 01INSInsider sell: General Counsel
Aug 21INSInsider buy: 10% owner
Aug 13INSInsider buy: Chief Executive Officer

Sign up to see the real GLSI record →

Company facts

SEC EDGAR registration

Name: Greenwich LifeSciences, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -55sample, -100 to +100
Reporting currency: USD

Who is positioning in GLSI

sample

Insiders: 16 insider transactions over 90 days, net selling, $102.9M
Congress: 3 members traded over 90 days
Institutions · 13F: 19 funds hold $8.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$30.1B +16.5% y/y

Q4 2024Q3 2026

Inventory$17.3B +9.8% y/y

Q4 2024Q3 2026

Accounts receivable$12.8B +6.5% y/y

Q4 2024Q3 2026

Total debt$34.7B +15.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $430.5B -11.0% 3M
Sample peer B: $67.7B -4.7% 3M
Sample peer C: $159.7B +1.0% 3M
Sample peer D: $62.7B +1.8% 3M
Sample peer E: $212.9B -5.7% 3M